Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
SHANK3 (also known as ProSAP2) regulates the structural organization of dendritic spines and is a binding partner of neuroligins; genes encoding neuroligins are mutated in autism and Asperger syndrome. Here, we report that a mutation of a single copy of SHANK3 on chromosome 22q13 can result in language and/or social communication disorders. These mutations concern only a small number of individuals, but they shed light on one gene dosage-sensitive synaptic pathway that is involved in autism spectrum disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Loss of a functional copy of the SHANK3 gene leads to the neurobehavioral manifestations of 22q13 deletion syndrome and/or to autism spectrum disorders.”
From Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication (2010) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The variations identified included de novo deleterious mutations and inherited non-synonymous variations affecting highly conserved amino acids in the ankyrin domain.6, 7”
From SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism (2012) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The remaining three mutations are non-synonymous mutations located in or near the highly conserved ankyrin domain (R12C, R300C and Q321R, referred to as Shank3R12C, Shank3R300C and Shank3Q321R, respectively).6, 7”
From SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism (2012) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent human genetic studies indicate that SHANK family genes (SHANK1, SHANK2, and SHANK3) are causative genes for idiopathic autism spectrum disorders (ASD).”
From Modeling Autism by SHANK Gene Mutations in Mice (2013) · cites this paper as Durand et al., 2007
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In three families from France and Canada, the SHANK3 deletions originated from a balanced translocation present in a healthy parent [6], [13].”
From Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: A Gradient of Severity in Cognitive Impairments (2014) · cites this paper as [6]
Experimental — accuracy not yet measured
21 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A forkhead-domain gene is mutated in a severe speech and language disorder
Lai, C. S. L., Fisher, S. E., Hurst, J. A., Vargha-Khadem, F., & Monaco, A. P. (2001) · Nature · doi:10.1038/35097076 · Cited by 2,054
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism
Study, P. A. R. I. S., Jamain, S., Quach, H., Betancur, C., Råstam, M., Colineaux, C., Gillberg, I. C., Soderstrom, H., Giros, B., Leboyer, M., et al. (2003) · Nature Genetics · doi:10.1038/ng1136 · Cited by 1,851
Self-citationNaisbitt, S., Kim, E., Tu, J. C., Xiao, B., Sala, C., Valtschanoff, J., Weinberg, R. J., Worley, P. F., & Sheng, M. (1999) · Neuron · doi:10.1016/s0896-6273(00)80809-0 · Cited by 1,009
Genetics of austim: complex aetiology for a heterogeneous disorder
Folstein, S. E., & Rosen-Sheidley, B. (2001) · Nature Reviews Genetics · doi:10.1038/35103559 · Cited by 771
Searching for ways out of the autism maze: genetic, epigenetic and environmental clues
Persico, A. M., & Bourgeron, T. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.05.010 · Cited by 575
Self-citationVorstman, J. A. S., Staal, W. G., van Daalen, E., van Engeland, H., Hochstenbach, P. F. R., & Franke, L. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001757 · Cited by 353
Spine architecture and synaptic plasticity
Carlisle, H. J., & Kennedy, M. B. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.01.008 · Cited by 350
Boeckers, T. M., Bockmann, J., Kreutz, M. R., & Gundelfinger, E. D. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00931.x · Cited by 349
Self-citationSevere Expressive-Language Delay Related to Duplication of the Williams–Beuren Locus
Somerville, M. J., Mervis, C. B., Young, E. J., Seo, E.-J., del Campo, M., Bamforth, S., Peregrine, E., Loo, W., Lilley, M., Pérez-Jurado, L. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051962 · Cited by 312
Bonaglia, M. C., Giorda, R., Borgatti, R., Felisari, G., Gagliardi, C., Selicorni, A., & Zuffardi, O. (2001) · The American Journal of Human Genetics · doi:10.1086/321293 · Cited by 309
Cited by
Items 301–400 of 1,004
Autism spectrum disorders: The quest for genetic syndromes
Zafeiriou, D. I., Ververi, A., Dafoulis, V., Kalyva, E., & Vargiami, E. (2013) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32152 · Cited by 107
Hung, A. Y., Sung, C. C., Brito, I. L., & Sheng, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009842 · Cited by 106
“Furthermore, mutations in members of the GKAP/SAPAP and Shank family of genes may contribute to obsessive-compulsive and autism spectrum disorders, respectively [43–45], indicating that proper regulation of the turnover of these proteins is critical for normal cognitive functions.”
BackgroundSerret, S., Thümmler, S., Dor, E., Vesperini, S., Santos, A., & Askenazy-Gittard, F. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0490-1 · Cited by 116
“structural organization of dendritic spines, and a binding partner of neuroligins [4].”
BackgroundEgger, G., Roetzer, K. M., Noor, A., Lionel, A. C., Mahmood, H., Schwarzbraun, T., Boright, O., Mikhailov, A., Marshall, C. R., Windpassinger, C., et al. (2014) · Neurogenetics · doi:10.1007/s10048-014-0394-0 · Cited by 124
“300830) [7–11].”
Common genetic variants on 1p13.2 associate with risk of autism
Xia, K., Guo, H., Hu, Z., Xun, G., Zuo, L., Peng, Y., Wang, K., He, Y., Xiong, Z., Sun, L., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.146 · Cited by 116
Do common variants play a role in risk for autism? Evidence and theoretical musings
Devlin, B., Melhem, N., & Roeder, K. (2011) · Brain Research · doi:10.1016/j.brainres.2010.11.026 · Cited by 105
“Thus far more of the genetics of risk traces to rare variation (Jamain et al., 2003; Durand et al., 2006; Sebat et al., 2007; Marshall et al., 2008; Weiss et al., 2008; Kumar et al., 2008; Glessner et al., 2009; Fernandez et al., 2010; Pinto et al., 2010).”
BackgroundScaffolding proteins at the postsynaptic density: shank as the architectural framework
Kreienkamp, H. J. (2008) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-72843-6_15 · Cited by 105
“In addition, point mutations leading to frame shifts or alterations in the protein sequence have been described recently (Durand et al. 2007).”
BackgroundHomer1a-Dependent Crosstalk Between NMDA and Metabotropic Glutamate Receptors in Mouse Neurons
Bertaso, F., Roussignol, G., Worley, P., Bockaert, J., Fagni, L., & Ango, F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009755 · Cited by 105
“Such crosstalk could also contribute to psychiatric disorders, since a Shank3 deletion mutant lacking the Homer binding site has been identified in autism [18].”
Current Developments in the Genetics of Autism: From Phenome to Genome
Losh, M., Sullivan, P. F., Trembath, D., & Piven, J. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318184482d · Cited by 105
“In another study evaluating sequence and copy number variants in the SHANK3 region, Moessner et al (86) detected 1 de novo mutation and 2 gene deletions in a group of 400 individuals with autism.”
InfluentialHomann, O. R., Misura, K., Lamas, E., Sandrock, R. W., Nelson, P., McDonough, S. I., & DeLisi, L. E. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.24 · Cited by 104
Endothelial cell-derived GABA signaling modulates neuronal migration and postnatal behavior
Li, S., Pandit, P. K. T., Joshee, S., Kirschstein, T., Subburaju, S., Khalili, J. S., Kloepper, J., Du, C., Elkhal, A., Szabó, G., et al. (2017) · Cell Research · doi:10.1038/cr.2017.135 · Cited by 108
Drapeau, E., Riad, M., Kajiwara, Y., & Buxbaum, J. D. (2018) · eNeuro · doi:10.1523/eneuro.0046-18.2018 · Cited by 116
The Cerebellar Involvement in Autism Spectrum Disorders: From the Social Brain to Mouse Models
Mapelli, L., Soda, T., D'Angelo, E. U., & Prestori, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073894 · Cited by 123
“This gene is also known as MAPKIP2 or JIP2 and is located 70 kbp from SHANK3 [370,376].”
BackgroundInfluentialA role for synaptic zinc in ProSAP/Shank PSD scaffold malformation in autism spectrum disorders
Grabrucker, A. M. (2014) · Developmental Neurobiology · doi:10.1002/dneu.22089 · Cited by 103
“In contrast to ProSAP2/Shank3 and ProSAP1/Shank2, the Shank1 SAM domain is not required for localization of Shank1 to synapses (Boeckers et al., 2005) and it is probably only sufficiently targeted to PSDs with a preformed ProSAP2/ Shank3 and ProSAP1/Shank2 scaffold (Grabrucker et al., 2011b).”
BackgroundInfluentialActin filaments and microtubules in dendritic spines
Shirao, T., & González‐Billault, C. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12313 · Cited by 102
Genetic Basis of Intellectual Disability
Ellison, J. W., Rosenfeld, J. A., & Shaffer, L. G. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-042711-140053 · Cited by 103
Dahlhaus, R., & El-Husseini, A. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.11.019 · Cited by 102
Mutations in the gene encoding CADM1 are associated with autism spectrum disorder
Zhiling, Y., Fujita, E., Tanabe, Y., Yamagata, T., Momoi, T., & Momoi, M. Y. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.10.107 · Cited by 112
Genetic Copy Number Variation and General Cognitive Ability
MacLeod, A. K., Davies, G., Payton, A., Tenesa, A., Harris, S. E., Liewald, D. C. M., Ke, X., Luciano, M., Lopez, L. M., Gow, A. J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037385 · Cited by 104
“3 deletion syndrome, which is characterized by neonatal hypotonia, global developmental delay, severe cognitive deficits, normal to accelerated growth, absent to severely delayed speech, autistic behaviour, and minor dysmorphic features [73,75].”
BackgroundAmal, H., Barak, B., Bhat, V., Gong, G., Joughin, B. A., Wang, X., Wishnok, J. S., Feng, G., & Tannenbaum, S. R. (2020) · Molecular Psychiatry · doi:10.1038/s41380-018-0113-6 · Cited by 101
PAK2 Haploinsufficiency Results in Synaptic Cytoskeleton Impairment and Autism-Related Behavior
Wang, Y., Zeng, C., Li, J., Zhou, Z., Ju, X., Xia, S., Li, Y., Liu, A., Teng, H., Zhang, K., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.061 · Cited by 101
The Fragile X Family of Disorders: A Model for Autism and Targeted Treatments
Hagerman, R., Rivera, S., & Hagerman, P. (2008) · Current Pediatric Reviews · doi:10.2174/157339608783565770 · Cited by 100
“SHANK3 encodes a synaptic protein that is critical for proper brain development; point mutations of this gene cause ASD [21, 24].”
BackgroundCastermans, D., Volders, K., Crepel, A., Backx, L., De Vos, R., Freson, K., Meulemans, S., Vermeesch, J. R., Schrander-Stumpel, C. T. R. M., De Rijk, P., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq013 · Cited by 100
“Sequencing analysis of rs8033925 in the dissected amplified DNA from der (15) of the patient showed the A allele, consistent with affected expression from the aberrant chromosome 15.”
BackgroundMethodResultInfluentialAutism: highly heritable but not inherited
Beaudet, A. L. (2007) · Nature Medicine · doi:10.1038/nm0507-534 · Cited by 100
Alterations in CA1 hippocampal synapses in a mouse model of fragile X syndrome
Jawaid, S., Kidd, G. J., Wang, J., Swetlik, C., Dutta, R., & Trapp, B. D. (2018) · Glia · doi:10.1002/glia.23284 · Cited by 100
“In addition to those defined specifically as ASDs, many diseases with other neurological classifications are also included in the autism spectrum (Hagerman, Hoem, & Hagerman, 2010; Mefford et al., 2012).”
BackgroundInfluentialAMPA Receptors as Therapeutic Targets for Neurological Disorders
Lee, K., Goodman, L., Fourie, C., Schenk, S., Leitch, B., & Montgomery, J. M. (2015) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2015.10.004 · Cited by 122
Neuroimaging in autism—from basic science to translational research
Ecker, C., & Murphy, D. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.276 · Cited by 115
Dargenio, V. N., Dargenio, C., Castellaneta, S., De Giacomo, A., Laguardia, M., Schettini, F., Francavilla, R., & Cristofori, F. (2023) · Nutrients · doi:10.3390/nu15071620 · Cited by 98
“Multiple mutations in the gene encoding the synaptic scaffolding protein “SH3 and multiple ankyrin repeat domains 3” (SHANK3) have been found to be associated with ASD [136], altering cortical neuronal connectivity and increasing the risk of ASD diagnosis [137].”
BackgroundBerg, E. L., Copping, N. A., Rivera, J. K., Pride, M. C., Careaga, M., Bauman, M. D., Berman, R. F., Lein, P. J., Harony‐Nicolas, H., Buxbaum, J. D., et al. (2018) · Autism Research · doi:10.1002/aur.1925 · Cited by 98
“Reduced expression of SHANK3, which codes for a synaptic scaffolding protein, is hypothesized to lead to impairments in key brain functions underlying social communication and cognition [Durand et al., 2007].”
BackgroundUse of Transcranial Magnetic Stimulation in Autism Spectrum Disorders
Oberman, L. M., Rotenberg, A., & Pascual‐Leone, Á. (2013) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-013-1960-2 · Cited by 113
“Firstly, most candidate genes linked to ASD play a role in developmental and experience-dependent plasticity (Akaneya et al. 1997; Huber et al. 1998; Jiang et al. 2001; Korte et al. 1995; Patterson et al. 1996; Perry et al. 2001; Durand et al. 2007; Jamain et al. 2003; Morrow et al. 2008; Cook 2001; Lamb et al. 2000;…”
BackgroundA new look at an old drug: neuroprotective effects and therapeutic potentials of lithium salts
Carmassi, C., Del Grande, C., Gesi, C., Musetti, L., & Dell'Osso, L. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s106479 · Cited by 97
“3 that encodes a scaffold protein located at the glutamatergic synapses and involved in the regulation of the structural organization of dendritic spines and binding partner of neuroligins, accounting for approximately 2% of cases of intellectual disability in ASDs patients.(218) After deletion of SHANK3 gene, the ner…”
Cell Adhesion, the Backbone of the Synapse: "Vertebrate" and "Invertebrate" Perspectives
Giagtzoglou, N., Ly, C. V., & Bellen, H. J. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003079 · Cited by 97
“The scaffolding molecule and interacting protein of neuroligin SHANK3 (ProSAP2) is also associated with autism (Durand et al. 2007).”
BackgroundCellular and synaptic network defects in autism
Peça, J., & Feng, G. (2012) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2012.02.015 · Cited by 96
“Moreover, point mutations in the Shank3 gene have been identified in patients diagnosed with ASDs [18 ,25].”
D’Antoni, S., Spatuzza, M., Bonaccorso, C. M., Musumeci, S. A., Ciranna, L., Nicoletti, F., Huber, K. M., & Catania, M. V. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.02.003 · Cited by 96
“Interestingly, defects in mGlu5 receptor-dependent ERK1/2 phosphorylation were not rescued by overexpression of two Shank3 carrying mutations that have been found in patients with autism (Durand et al., 2007), suggesting that alteration of mGlu5 receptor signalling might be a common mechanism in Phelan Mc Dermid disea…”
BackgroundDarville, H., Poulet, A., Amsellem, F., Chatrousse, L., Pernelle, J., Boissart, C., Héron, D., Nava, C., Perrier, A. L., Jarrige, M., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.05.032 · Cited by 115
“SHANK3 haplo-insufficiency induced by heterozygous loss of function mutations represents a clear model of abnormal gene dosage leading to ASD (Durand et al., 2007; Yi et al., 2016) that can be reversed by genetically re-introducing SHANK3 normal levels of expression, including during adulthood, in…”
BackgroundInfluentialSelf-citationTau Reduction Prevents Key Features of Autism in Mouse Models
Tai, C., Chang, C.-W., Yu, G.-Q., Lopez, I., Yu, X., Wang, X., Guo, W., & Mucke, L. (2020) · Neuron · doi:10.1016/j.neuron.2020.01.038 · Cited by 96
“, 2003), and numerous mutations in SHANK3 have been identified in ASD patients without this syndrome, including de novo frameshift, truncation, and missense mutations (Durand et al., 2007; Monteiro and Feng, 2017).”
BackgroundAssociation and mutation analyses of 16p11.2 autism candidate genes
Kumar, R. A., Marshall, C. R., Badner, J. A., Babatz, T. D., Mukamel, Z., Aldinger, K. A., Sudi, J., Brune, C. W., Goh, G., KaraMohamed, S., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004582 · Cited by 95
“Although mutations associated with autism have been identified by screening as few as several hundred patients [32,33], one limitation of our study is the relatively small number of patients screened for rare variants.”
BackgroundSocial and non-social autism symptoms and trait domains are genetically dissociable
Warrier, V., Toro, R., Won, H., Leblond, C. S., Cliquet, F., Delorme, R., De Witte, W., Bralten, J., Chakrabarti, B., Børglum, A. D., et al. (2019) · Communications Biology · doi:10.1038/s42003-019-0558-4 · Cited by 94
Self-citationGenomic and genetic aspects of autism spectrum disorder
Liu, X., & Takumi, T. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.08.108 · Cited by 102
Stride-level analysis of mouse open field behavior using deep-learning-based pose estimation
Sheppard, K., Gardin, J., Sabnis, G. S., Peer, A., Darrell, M., Deats, S., Geuther, B. Q., Lutz, C. M., & Kumar, V. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110231 · Cited by 117
Identification and functional characterization of rare SHANK2 variants in schizophrenia
Peykov, S., Berkel, S., Schoen, M., Weiss, K., Degenhardt, F., Strohmaier, J., Weiss, B., Proepper, C., Schratt, G., Nöthen, M. M., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.172 · Cited by 93
Self-citationTranslational approaches to the biology of Autism: false dawn or a new era?
Ecker, C., Spooren, W., & Murphy, D. G. M. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.102 · Cited by 92
The therapeutic potential of insulin-like growth factor-1 in central nervous system disorders
Costales, J., & Kolevzon, A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.01.001 · Cited by 93
“Loss of SHANK3 is responsible for at least 0.5% of ASD cases (Durand et al., 2007) and up to 2% of ASD with moderate to profound intellectual disability (ID) (Leblond et al., 2014) .”
BackgroundInfluentialThe Genetics of Autism Spectrum Disorders
Huguet, G., Benabou, M., & Bourgeron, T. (2016) · Research and perspectives in endocrine interactions · doi:10.1007/978-3-319-27069-2_11 · Cited by 125
Self-citationDelling, J. P., & Boeckers, T. M. (2021) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-021-09397-8 · Cited by 109
“Additionally, SHANK3 mutations have been observed in both asymptomatic parents and their ASD-diagnosed children [28].”
BackgroundResultSelf-citationScaffold Proteins at the Postsynaptic Density
Verpelli, C., Schmeisser, M. J., Sala, C., & Boeckers, T. M. (2012) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-7091-0932-8_2 · Cited by 92
Self-citationAltered Balance of Proteolytic Isoforms of Pro-Brain-Derived Neurotrophic Factor in Autism
Garcia, K. L. P., Yu, G., Nicolini, C., Michalski, B., Garzon, D. J., Chiu, V. S., Tongiorgi, E., Szatmari, P., & Fahnestock, M. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31824b27e4 · Cited by 92
Freudenberg, F., Celikel, T., & Reif, A. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.03.005 · Cited by 105
Blaker-Lee, A., Gupta, S., McCammon, J. M., DeRienzo, G., & Sive, H. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.009944 · Cited by 92
“These include SHANK3 in 22q13 (Durand et al., 2007), RPA1 in 17q13.”
BackgroundKerr, J. M., & Blanpied, T. A. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2927-11.2012 · Cited by 91
“Given this, our model suggests disease-associated perturbations of the spine actin cytoskeleton or PSD (Bonaglia et al., 2001; Durand et al., 2007; Gauthier et al., 2010) may induce pathological disruption of synapse function even without overt loss of spines, through altered cytoskeletal control…”
MethodChen, Y.-K., & Hsueh, Y.-P. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4405-11.2012 · Cited by 90
“Human genetic studies have demonstrated the association of Shank3 mutations with autism or other psychiatric disorders (Bonaglia et al., 2001; Durand et al., 2007; Moessner et al., 2007).”
BackgroundNeumeyer, A. M., Anixt, J., Chan, J., Perrin, J. M., Murray, D., Coury, D. L., Bennett, A., Farmer, J., & Parker, R. A. (2019) · Academic Pediatrics · doi:10.1016/j.acap.2018.06.014 · Cited by 89
Psychiatric illness and regression in individuals with Phelan-McDermid syndrome
Kohlenberg, T. M., Trelles, M. P., McLarney, B., Betancur, C., Thurm, A. E., & Kolevzon, A. (2020) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-020-9309-6 · Cited by 98
“Significant cognitive and behavioral regression has been documented in PMS [5, 6, 9, 15, 16, 18, 41].”
BackgroundSelf-citationReplication study of candidate genes for cognitive abilities: the Lothian Birth Cohort 1936
Houlihan, L. M., Harris, S. E., Luciano, M., Gow, A. J., Starr, J. M., Visscher, P. M., & Deary, I. J. (2009) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2008.00470.x · Cited by 89
“Furthermore, we included a gene encoding a synaptic scaffolding protein, SHANK3, that is linked by functional biological evidence to autism (Durand et al. 2007).”
BackgroundIasevoli, F., Tomasetti, C., & de Bartolomeis, A. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0886-y · Cited by 105
“Indeed, recent reports have implicated de novo mutations in Shank3 gene in the susceptibility to autism spectrum disorder [41–44], and Kalirin has been crucially implicated in the vulnerability to schizophrenia [54].”
BackgroundDetection and Characterization of Copy Number Variation in Autism Spectrum Disorder
Marshall, C. R., & Scherer, S. W. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-507-7_5 · Cited by 111
Syndromic autism: causes and pathogenetic pathways
Benvenuto, A., Moavero, R., Alessandrelli, R., Manzi, B., & Curatolo, P. (2009) · World Journal of Pediatrics · doi:10.1007/s12519-009-0033-2 · Cited by 112
Contemplating effects of genomic structural variation
Buchanan, J. A., & Scherer, S. W. (2008) · Genetics in Medicine · doi:10.1097/gim.0b013e318183f848 · Cited by 100
Cederquist, G. Y., Tchieu, J., Callahan, S. J., Ramnarine, K., Ryan, S., Zhang, C., Rittenhouse, C., Zeltner, N., Chung, S. Y., Zhou, T., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.06.004 · Cited by 84
Epigenetic Findings in Autism: New Perspectives for Therapy
Siniscalco, D., Cirillo, A., Bradstreet, J. J., & Antonucci, N. (2013) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph10094261 · Cited by 96
“This gene comprises five CpG-islands, and it is associated with autism [29].”
BackgroundHunter, J. W., Mullen, G. P., McManus, J. R., Heatherly, J. M., Duke, A., & Rand, J. B. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.003442 · Cited by 86
“Support for this model increased with reports that mutations in the genes encoding shank 3 (a postsynaptic scaffolding protein) and neurexin 1 are also associated with autism (Durand et al., 2007; Moessner et al., 2007; The Autism Genome Project Consortium, 2007; Kim et al., 2008).”
ResultKozol, R. A., Cukier, H. N., Zou, B., Mayo, V., De Rubeis, S., Cai, G., Griswold, A. J., Whitehead, P. L., Haines, J. L., Gilbert, J. R., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv138 · Cited by 86
Corradi, A., Fadda, M., Piton, A., Patry, L., Marte, A., Rossi, P., Cadieux-Dion, M., Gauthier, J., Lapointe, L., Mottron, L., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt401 · Cited by 86
“Notably, the majority of the ASD-predisposing genes thus far identified encode for synaptic proteins, such as the postsynaptic proteins neuroligins 3 and 4 (NLGN3, NLGN4), their cytoplasmic interactors SHANK2 and SHANK3 and their presynaptic partner neurexin-1 (NRXN1) (5–13).”
BackgroundChilian, B., Abdollahpour, H., Bierhals, T., Haltrich, I., Fekete, G., Nagel, I., Rosenberger, G., & Kutsche, K. (2013) · Clinical Genetics · doi:10.1111/cge.12105 · Cited by 85
Wilson, H. L., Crolla, J. A., Walker, D., Artifoni, L., Dallapiccola, B., Takano, T., Vasudevan, P., Huang, S., Maloney, V., Yobb, T., et al. (2008) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.107 · Cited by 85
Sarasua, S. M., Dwivedi, A., Boccuto, L., Chen, C.-F., Sharp, J. L., Rollins, J. D., Collins, J. S., Rogers, R. C., Phelan, K., & DuPont, B. R. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.144 · Cited by 92
Cochoy, D. M., Kolevzon, A., Kajiwara, Y., Schoen, M., Pascual‐Lucas, M., Lurie, S., Buxbaum, J. D., Boeckers, T. M., & Schmeißer, M. J. (2015) · Molecular Autism · doi:10.1186/s13229-015-0020-5 · Cited by 98
“SHANK gene family plays a decisive role because diverse genetic variation in SHANK1, SHANK2, and SHANK3 - all encoding large postsynaptic scaffold proteins - has been identified in individuals with ASD [10-16].”
BackgroundResultSelf-citationLinkage and candidate gene studies of autism spectrum disorders in European populations
Holt, R., Barnby, G., Maestrini, E., Bacchelli, E., Brocklebank, D., Sousa, I., Mulder, E. J., Kantojärvi, K., Järvelä, I. E., Klauck, S. M., et al. (2010) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.69 · Cited by 97
Mejias, R., Adamczyk, A., Anggono, V., Niranjan, T., Thomas, G. M., Sharma, K., Skinner, C., Schwartz, C. E., Stevenson, R. E., Fallin, M. D., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102233108 · Cited by 84
Both rare and common genetic variants contribute to autism in the Faroe Islands
Leblond, C. S., Cliquet, F., Carton-Buonafine, C., Huguet, G., Mathieu, A., Kergrohen, T., Buratti, J., Lemière, N., Cuisset, L., Bienvenu, T., et al. (2019) · npj Genomic Medicine · doi:10.1038/s41525-018-0075-2 · Cited by 96
“Based on the genes previously reported (NLGN3, NLGN4X, duplication of SHANK3) (55,56) and the genes found in this study (RIMS4, KALRN, PLA2G4A), it seems that the proteins involved in autism without ID converge to different part of the post- and pre-synapse rather than to pathways such as gene regulation and chromatin…”
Self-citationDamiani, F., Cornuti, S., & Tognini, P. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109491 · Cited by 100
Vaccarino, F. M., Grigorenko, E. L., Smith, K. M., & Stevens, H. E. (2009) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-008-0653-8 · Cited by 84
“For example, the development or maintenance of synaptic connections may be affected in autism, and indeed, rare mutations have been reported in ASD for both neuroligins (Jamain et al. 2003; Laumonnier et al. 2004), the associated neurexins (Feng et al. 2006) and SHANK (Durand et al. 2007), molecules which are associat…”
Maussion, G., Carayol, J., Lepagnol-Bestel, A.-M., Tores, F., Loe-Mie, Y., Milbreta, U., Rousseau, F., Fontaine, K., Renaud, J., Moalic, J.-M., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn154 · Cited by 84
Paciorkowski, A. R., Thio, L. L., Rosenfeld, J. A., Gajęcka, M., Gurnett, C. A., Kulkarni, S., Chung, W. K., Marsh, E. D., Gentile, M., Reggin, J. D., et al. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.121 · Cited by 92
CaMKIIα-driven, phosphatase-checked postsynaptic plasticity via phase separation
Cai, Q., Zeng, M., Wu, X., Wu, H., Zhan, Y., Tian, R., & Zhang, M. (2021) · Cell Research · doi:10.1038/s41422-020-00439-9 · Cited by 83
Calahorro, F., & Ruiz‐Rubio, M. (2011) · Invertebrate Neuroscience · doi:10.1007/s10158-011-0126-1 · Cited by 99
“On the other hand, several recent studies have implicated some mutations, deletions and duplications in the Shank family of proteins, especially Shank3, with ASD (Berkel et al. 2010; Durand et al. 2007; Moessner et al. 2007).”
BackgroundSapap3 Deletion Anomalously Activates Short-Term Endocannabinoid-Mediated Synaptic Plasticity
Chen, M., Wan, Y., Ade, K., Ting, J., Feng, G., & Calakos, N. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1701-11.2011 · Cited by 82
“Shank3 mutation is associated with a form of autism (Durand et al., 2007).”
Kolevzon, A., Delaby, E., Berry‐Kravis, E., Buxbaum, J. D., & Betancur, C. (2019) · Molecular Autism · doi:10.1186/s13229-019-0291-3 · Cited by 93
“…1 PMS patients with neuropsychiatric decompensation reported in the literature (Continued) Case 13 14 15 16 17 18 Reference Durand et al. (2007) [2] Durand et al. (2007) [2] Gauthier et al. (2010) [28] Gauthier et al. (2010) [28] Gauthier et al. (2010) [28] Gauthier et al. (2010) [28] Subject…”
BackgroundInfluentialSelf-citationThe neuroligins and the synaptic pathway in Autism Spectrum Disorder
Trobiani, L., Meringolo, M., Diamanti, T., Bourne, Y., Marchot, P., Martella, G., Dini, L., Pisani, A., Jaco, A. D., & Bonsi, P. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.09.017 · Cited by 94
Castermans, D., Vermeesch, J. R., Fryns, J., Steyaert, J. G., de Ven, W. J. M. V., Creemers, J. W. M., & Devriendt, K. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201785 · Cited by 97
CANDID: a flexible method for prioritizing candidate genes for complex human traits
Hutz, J. E., Kraja, A. T., McLeod, & Province, M. A. (2008) · Genetic Epidemiology · doi:10.1002/gepi.20346 · Cited by 82
Wang, Z.-J., Zhong, P., Ma, K., Seo, J.-S., Yang, F., Hu, Z., Zhang, F., Lin, L., Wang, J., Liu, T., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0351-2 · Cited by 82
Autism genetics: emerging data from genome-wide copy-number and single nucleotide polymorphism scans
Weiss, L. A. (2009) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.09.59 · Cited by 80
Li, K., Li, L., Cui, B., Gai, Z., Li, Q., Wang, S., Yan, J., Lin, B., Tian, L., Liu, H., et al. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfx240 · Cited by 80
Lang, D. G., Schott, B. H., van Ham, M., Morton, L., Kulikovskaja, L., Herrera‐Molina, R., Pielot, R., Klawonn, F., Montag, D., Jänsch, L., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1242-1 · Cited by 78
Phelan McDermid Syndrome: From Genetic Discoveries to Animal Models and Treatment
Harony-Nicolas, H., De Rubeis, S., Kolevzon, A., & Buxbaum, J. D. (2015) · Journal of Child Neurology · doi:10.1177/0883073815600872 · Cited by 81
“De novo and inherited SHANK3 mutations have been found in individuals with autism spectrum disorder.(15,23) By transfecting wild-type and mutant SHANK3 in primary hippocampal neurons, independent studies have found that 3 of the reported Harony-Nicolas et al 1863”
BackgroundMethodKuwano, Y., Kamio, Y., Kawai, T., Katsuura, S., Inada, N., Takaki, A., & Rokutan, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024723 · Cited by 81
“For example, ASD-associated genes include glutamate receptors, gamma-aminobutyric acid (GABA) receptors, neuroligins (NLGNs), neurexin 1, SH3 and multiple ankyrin repeat domains 3 (SHANK3), which are involved in synapse formation and function [8], [9], [10], [11], [12].”
BackgroundJiang-Xie, L.-F., Liao, H.-M., Chen, C.-H., Chen, Y.-T., Ho, S.-Y., Lu, D.-H., Lee, L.-J., Liou, H.-H., Fu, W.-M., & Gau, S. S.-F. (2014) · Molecular Autism · doi:10.1186/2040-2392-5-32 · Cited by 79
“Interestingly, we found that DLGAP2 regulates social behaviors in a totally different way from SHANKs.”
BackgroundInfluentialMicrodeletion and Microduplication Syndromes
Vissers, L. E. L. M., & Stankiewicz, P. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-507-7_2 · Cited by 98
Stolp, H., Neuhaus, A., Sundramoorthi, R., & Molnár, Z. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00050 · Cited by 80
Reim, D., Distler, U., Halbedl, S., Verpelli, C., Sala, C., Bockmann, J., Tenzer, S., Boeckers, T. M., & Schmeisser, M. J. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00026 · Cited by 80
“ORIGINAL RESEARCH published: 14 February 2017 doi: 10.3389/fnmol.2017.00026 Edited by: Rolf Sprengel, Max Planck Institute for Medical Research (MPG), Germany Reviewed by: Eunjoon Kim, Institute for Basic Science (IBS) and Korea Advanced Institute of Science and Technology (KAIST), South Korea Takashi Hayashi, Nationa…”
BackgroundSelf-citationNovel variants identified in methyl-CpG-binding domain genes in autistic individuals
Cukier, H. N., Rabionet, R., Konidari, I., Rayner-Evans, M. Y., Baltos, M. L., Wright, H. H., Abramson, R. K., Martin, E. R., Cuccaro, M. L., Pericak-Vance, M. A., et al. (2010) · neurogenetics · doi:10.1007/s10048-009-0228-7 · Cited by 80
“H. N. Cukier : I. Konidari :M. Y. Rayner-Evans :M. L. Baltos : E. R. Martin :M. L. Cuccaro :M. A. Pericak-Vance : J. R. Gilbert (*) John P. Hussman Institute for Human Genomics, University of Miami, 1501 NW 10th Avenue, Miami, FL 33136, USA e-mail: jgilbert@med.miami.edu R. Rabionet Genes and Disease Program, Centre d…”
A framework to identify contributing genes in patients with Phelan-McDermid syndrome
Tabet, A., Rolland, T., Ducloy, M., Lévy, J., Buratti, J., Mathieu, A., Haye, D., Perrin, L., Dupont, C., Passemard, S., et al. (2017) · npj Genomic Medicine · doi:10.1038/s41525-017-0035-2 · Cited by 96
Self-citationMercati, O., Huguet, G., Danckaert, A., André-Leroux, G., Maruani, A., Bellinzoni, M., Rolland, T., Gouder, L., Mathieu, A., Buratti, J., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.61 · Cited by 78
“23,81 Both CNTN5 and CNTN6 are also expressed in the inferior colliculus, the principal midbrain nucleus of the auditory pathway.”
Self-citationMolecular mechanisms of cognitive and behavioral comorbidities of epilepsy in children
Brooks‐Kayal, A. R. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2010.02906.x · Cited by 91
“Mutations in neuroligin (NL)-1, -3, and -4 have been identified in human patients with ASDs (Jamain et al., 2003; Durand et al., 2007).”
BackgroundNeurexin Dysfunction in Adult Neurons Results in Autistic-like Behavior in Mice
Rabaneda, L. G., Robles-Lanuza, E., Nieto-González, J. L., & Scholl, F. G. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.06.022 · Cited by 78
“The identification of mutations in NLGN and SHANK genes in ASD pointed to glutamatergic dysfunction of the NRNX-NLGN-SHANK pathway in autism (Durand et al., 2007; Jamain et al., 2003; Laumonnier et al., 2004).”
BackgroundCarter, M., Nikkel, S., Fernandez, B., Marshall, C., Noor, A., Lionel, A., Prasad, A., Pinto, D., Joseph-George, A., Noakes, C., et al. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01578.x · Cited by 77
“Symbols containing a capital T carry a balanced translocation [t(19;21)(p13.”
BackgroundGrabrucker, A. M., Schmeisser, M. J., Udvardi, P. T., Arons, M., Schoen, M., Woodling, N. S., Andreasson, K. I., Hof, P. R., Buxbaum, J. D., Garner, C. C., et al. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-65 · Cited by 76
“Proteins of the ProSAP/Shank (Synamon, CortBP, Spank, SSTRIP) family play a crucial role in proper synapse function [8] and have been linked to autism, schizophrenia and AD [7-13].”
BackgroundSelf-citationWu, Y., Ji, T., Wang, J., Xiao, J., Wang, H., Li, J., Gao, Z., Yang, Y., Cai, B., Wang, L., et al. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-72 · Cited by 89
“De novo deletions and mutations of SHANK3 have been found in individuals with autism [43-47].”
BackgroundModeling autism-relevant behavioral phenotypes in rats and mice: Do ‘autistic’ rodents exist?
Servadio, M., Vanderschuren, L. J. M. J., & Trezza, V. (2015) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000163 · Cited by 76
“Three different nonsense mutations in SHANK3, the intracellular binding partner for NLGNs, have also been found in patients with ASD (Durand et al., 2007).”
Metadata
- Authors
- Durand, C. M., Betancur, C., Boeckers, T. M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I. C., Anckarsäter, H., Sponheim, E., Goubran-Botros, H., Delorme, R., Chabane, N., Mouren-Simeoni, M.-C., de Mas, P., Bieth, E., Rogé, B., Héron, D., Burglen, L., Gillberg, C., Leboyer, M., & Bourgeron, T.
- Affiliations
- Institut Pasteur (FR)
- Inserm (FR)
- Universität Ulm (DE)
- University of Gothenburg (SE)
- University of Oslo (NO)
- Assistance Publique – Hôpitaux de Paris (FR)
- Université Toulouse - Jean Jaurès (FR)
- Pitié-Salpêtrière Hospital (FR)
- St George's Hospital (GB)
- Corresponding author
- Bourgeron, Thomas
- ORCID
- Venue
- Nature Genetics
- Published
- 2006-12-17
- Volume
- 39
- Issue
- 1
- Pages
- 25-27
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- PMC
- PMC2082049
- OpenAlex
- W1983194657
- Cited by
- 1,602
- References
- 16
- Citations by year
- 2026: 48 · 2025: 40 · 2024: 75 · 2023: 71 · 2022: 78 · 2021: 91 · 2020: 85 · 2019: 68 · 2018: 81 · 2017: 99 · 2016: 79 · 2015: 96 · 2014: 78 · 2013: 97 · 2012: 114
- FWCI
- 33.51
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion, other-oa)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- George Washington University
- Georgetown University
- Children's National Hospital
- European Commission
- Deutsche Forschungsgemeinschaft (SFB 497)
- Institut National de la Santé et de la Recherche Médicale
- Fondation pour la Recherche Médicale
- Fondation de France
- Universitetet i Oslo
- Assistance publique-Hôpitaux de Paris
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- SHANK3, autism spectrum disorder, neuroligins, dendritic spines, synaptic scaffolding, chromosome 22q13, gene dosage sensitivity, language disorders, social communication disorder, Asperger syndrome
- MeSH terms
- Autistic Disorder, Base Sequence, Carrier Proteins, DNA Mutational Analysis, Female, Genetic Testing, Humans, Male, Molecular Sequence Data, Mutation, Nerve Tissue Proteins, Pedigree, In Situ Hybridization, Fluorescence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.